Published in Stroke on August 09, 2007
Space Flap for Cerebral Protection Following Decompressive Hemicraniectomy for Stroke | NCT04865757
Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab (2010) 2.04
Health state preferences and decision-making after malignant middle cerebral artery infarctions. Neurology (2010) 1.52
Decompressive craniectomy: past, present and future. Nat Rev Neurol (2013) 1.24
Novel treatment targets for cerebral edema. Neurotherapeutics (2012) 1.20
Cranioplasty after decompressive craniectomy: An institutional audit and analysis of factors related to complications. Surg Neurol Int (2011) 1.16
Decompressive craniectomy in patients with cerebral infarction due to malignant vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosci Rural Pract (2012) 1.10
Quality of life and neurobehavioral changes in survivors of malignant middle cerebral artery infarction. J Neurol (2009) 1.02
Outcome following decompressive craniectomy for malignant middle cerebral artery infarction in patients older than 70 years old. J Cerebrovasc Endovasc Neurosurg (2012) 1.02
Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia. J Cereb Blood Flow Metab (2013) 1.01
Hemicraniectomy: a new model for human electrophysiology with high spatio-temporal resolution. J Cogn Neurosci (2010) 0.98
Clinical review: Therapy for refractory intracranial hypertension in ischaemic stroke. Crit Care (2007) 0.94
CT perfusion-guided patient selection for endovascular recanalization in acute ischemic stroke: a multicenter study. J Neurointerv Surg (2012) 0.89
Craniectomy for malignant cerebral infarction: prevalence and outcomes in US hospitals. PLoS One (2011) 0.89
Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial: randomized pilot clinical trial. Stroke (2014) 0.89
Stroke management. Ann Indian Acad Neurol (2011) 0.84
Decompressive craniectomy for malignant middle cerebral artery infarction: Impact on mortality and functional outcome. Surg Neurol Int (2014) 0.84
Predictors for good functional outcome after neurocritical care. Crit Care (2010) 0.83
Outcome of decompressive craniectomy in comparison to nonsurgical treatment in patients with malignant MCA infarction. Springerplus (2014) 0.83
Hemicraniectomy in the management of malignant middle cerebral artery infarction: Lessons from randomized, controlled trials. Surg Neurol Int (2014) 0.83
How often are patients with ischemic stroke eligible for decompressive hemicraniectomy? Stroke (2011) 0.83
Critical care for patients with massive ischemic stroke. J Stroke (2014) 0.83
Cognition after malignant media infarction and decompressive hemicraniectomy--a retrospective observational study. BMC Neurol (2011) 0.82
Decompressive surgery for malignant supratentorial infarction remains underutilized after guideline publication. J Neurol (2011) 0.82
Hemicraniectomy: a second chance on life for patients with space-occupying MCA infarction. Stroke (2007) 0.81
Tracheostomy after severe ischemic stroke: a population-based study. J Stroke Cerebrovasc Dis (2013) 0.80
Outcomes in severe middle cerebral artery ischemic stroke. Neurocrit Care (2014) 0.80
Antiplatelet therapy, but not intravenous thrombolytic therapy, is associated with postoperative bleeding complications after decompressive craniectomy for stroke. J Neurol (2013) 0.80
Updated Korean Clinical Practice Guidelines on Decompressive Surgery for Malignant Middle Cerebral Artery Territory Infarction. J Stroke (2015) 0.80
Where are We Now with Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Infarction? J Cerebrovasc Endovasc Neurosurg (2013) 0.79
Decompressive hemicraniectomy in supra-tentorial malignant infarcts. Surg Neurol Int (2012) 0.78
Decompressive craniectomy for the treatment of malignant infarction of the middle cerebral artery. Sci Rep (2014) 0.78
DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY - Registry (DESTINY-R): design and protocols. BMC Neurol (2012) 0.78
Reduction of Midline Shift Following Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Infarction. J Stroke (2016) 0.77
Quantification of errors in ordinal outcome scales using shannon entropy: effect on sample size calculations. PLoS One (2013) 0.77
Childhood hemorrhagic stroke: an important but understudied problem. J Child Neurol (2011) 0.77
Immersion autometallographic demonstration of pathological zinc accumulation in human acute neural diseases. Neurol Sci (2011) 0.77
Elevated Intracranial Pressure and Cerebral Edema following Permanent MCA Occlusion in an Ovine Model. PLoS One (2015) 0.77
Access to reliable information about long-term prognosis influences clinical opinion on use of lifesaving intervention. PLoS One (2012) 0.77
Stroke management. BMJ Clin Evid (2011) 0.77
Factors influencing the outcome (GOS) in reconstructive cranioplasty. Neurosurg Rev (2015) 0.77
Decompressive hemicraniectomy for ischemic stroke in the pediatric population. Neurosurg Rev (2012) 0.77
The clinical efficacy of decompressive craniectomy in patients with an internal carotid artery territory infarction. J Korean Neurosurg Soc (2012) 0.75
Decompressive craniectomy and early cranioplasty in a 15-year-old boy with N. meningitidis meningitis. Surg Neurol Int (2015) 0.75
Benefits of hemicraniectomy seen many years after malignant stroke in a young patient. Front Neurol (2012) 0.75
Functional Outcome After Decompressive Craniectomy in Patients with Dominant or Non-Dominant Malignant Middle Cerebral Infarcts. Cureus (2017) 0.75
Early decompressive craniectomy for malignant cerebral infarction: Meta-analysis and clinical decision algorithm. Neurol Clin Pract (2016) 0.75
Decompressive craniectomy after unsuccessful intravenous thrombolysis of malignant cerebral infarction. Iran J Neurol (2014) 0.75
Revisiting Hemicraniectomy: Late Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Stroke and the Role of Infarct Growth Rate. Stroke Res Treat (2017) 0.75
Analyses Using Micro-CT Scans and Tissue Staining on New Bone Formation and Bone Fusion According to the Timing of Cranioplasty via Frozen Autologous Bone Flaps in Rabbits : A Preliminary Report. J Korean Neurosurg Soc (2015) 0.75
Care of the stroke patient: routine management to lifesaving treatment options. Neurotherapeutics (2011) 0.75
Hemicraniectomy versus medical treatment with large MCA infarct: a review and meta-analysis. BMJ Open (2016) 0.75
German Cranial Reconstruction Registry (GCRR): protocol for a prospective, multicentre, open registry. BMJ Open (2015) 0.75
Extended Use of Hypothermia in Elderly Patients with Malignant Cerebral Edema as an Alternative to Hemicraniectomy. J Stroke (2016) 0.75
Outcome after decompressive craniectomy in patients with dominant middle cerebral artery infarction: A preliminary report. Ann Indian Acad Neurol (2013) 0.75
Decompressive Hemicraniectomy in a South American Population - Morbidity and Outcomes Analysis. PLoS One (2016) 0.75
Decompressive Craniectomy in Traumatic Brain Injury: A Review Article. Korean J Neurotrauma (2017) 0.75
Quality of life after surgical decompression for a space-occupying middle cerebral artery infarct: A cohort study. BMC Neurol (2015) 0.75
Decompressive craniectomy for severe traumatic brain injury: clinical study, literature review and meta-analysis. Springerplus (2016) 0.75
A simple prediction score system for malignant brain edema progression in large hemispheric infarction. PLoS One (2017) 0.75
Acute supratentorial ischemic stroke: when surgery is mandatory. Biomed Res Int (2014) 0.75
Evidence-based neurocritical care. Neurohospitalist (2014) 0.75
Radiological imaging features of the basal ganglia that may predict progression to hemicraniectomy in large territory middle cerebral artery infarct. Neuroradiology (2017) 0.75
Prediction of infarction volume and infarction growth rate in acute ischemic stroke. Sci Rep (2017) 0.75
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet (2007) 10.74
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol (2009) 7.73
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell (2012) 6.71
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol (2007) 6.15
Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med (2014) 5.79
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71
Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke (2009) 5.28
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace (2013) 5.16
Dissecting the genomic complexity underlying medulloblastoma. Nature (2012) 4.77
Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord (2004) 4.64
Acupuncture and knee osteoarthritis: a three-armed randomized trial. Ann Intern Med (2006) 4.42
Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet (2008) 4.14
Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol (2008) 3.91
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest (2005) 3.22
Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res (2008) 3.22
Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke (2008) 3.21
Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke (2004) 3.07
Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke (2006) 3.03
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med (2003) 2.94
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77
European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke (2014) 2.71
Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke (2012) 2.64
Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol (2009) 2.64
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke (2007) 2.54
EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J (2013) 2.52
Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke (2009) 2.51
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke (2006) 2.43
Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke (2003) 2.42
MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol (2006) 2.42
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet (2013) 2.42
Spreading depolarisations and outcome after traumatic brain injury: a prospective observational study. Lancet Neurol (2011) 2.40
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace (2015) 2.35
European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc Dis (2003) 2.35
Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 hours after onset. Stroke (2002) 2.33
An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial. Eur Heart J (2007) 2.31
Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain (2006) 2.29
Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke (2004) 2.24
Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol (2010) 2.12
Endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome. Stroke (2013) 2.11
Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res (2010) 2.07
Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain (2009) 2.06
Outcome after less-invasive decompression of lumbar spinal stenosis: a randomized comparison of unilateral laminotomy, bilateral laminotomy, and laminectomy. J Neurosurg Spine (2005) 1.99
Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med (2007) 1.99
Surgical decompression of patients with large middle cerebral artery infarcts is effective. Stroke (2003) 1.98
Spreading depolarizations occur in human ischemic stroke with high incidence. Ann Neurol (2008) 1.97
Impact of age-related cerebral white matter changes on the transition to disability -- the LADIS study: rationale, design and methodology. Neuroepidemiology (2005) 1.92
Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis (2006) 1.91
Genome of Herbaspirillum seropedicae strain SmR1, a specialized diazotrophic endophyte of tropical grasses. PLoS Genet (2011) 1.91
Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke (2003) 1.90
Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra? Stroke (2003) 1.90
Smoking, clopidogrel, and mortality in patients with established cardiovascular disease. Circulation (2009) 1.77
Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75
Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke (2002) 1.73
Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain (2005) 1.73
Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants. Stroke (2009) 1.69
Acute stroke imaging research roadmap. Stroke (2008) 1.66
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol (2014) 1.66
The main components of stroke unit care: results of a European expert survey. Cerebrovasc Dis (2007) 1.64
Baroreflex: a new therapeutic target in human stroke? Stroke (2009) 1.62
Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials. Stroke (2007) 1.62
Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. Stroke (2009) 1.61
Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clin Cancer Res (2009) 1.61
Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β. Clin Cancer Res (2011) 1.61
Diagnosing ICD-10 depressive episodes: superior criterion validity of the Patient Health Questionnaire. Psychother Psychosom (2004) 1.59
Detecting panic disorder in medical and psychosomatic outpatients: comparative validation of the Hospital Anxiety and Depression Scale, the Patient Health Questionnaire, a screening question, and physicians' diagnosis. J Psychosom Res (2003) 1.58
Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours. Cancer Treat Rev (2006) 1.58
Watertight dural closure: is it necessary? A prospective randomized trial in patients with supratentorial craniotomies. Neurosurgery (2008) 1.57
Differential recovery of behavioral status and brain function assessed with functional magnetic resonance imaging after mild traumatic brain injury in the rat. Crit Care Med (2007) 1.56
Intraoperative control of extracranial-intracranial bypass patency by near-infrared indocyanine green videoangiography. J Neurosurg (2005) 1.56
Assisted reproductive techniques and risk of exstrophy-epispadias complex: a German case-control study. J Urol (2012) 1.55
Intra-arterial thrombolysis is the treatment of choice for basilar thrombosis: pro. Stroke (2006) 1.55
Posterior reversible encephalopathy syndrome. J Intensive Care Med (2011) 1.55
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial. Eur Heart J (2013) 1.53